BioCentury
ARTICLE | Clinical News

Avicidin cancer therapy: Beginning a Phase I study

December 13, 1993 8:00 AM UTC

NeoRx Corp. (NERX) Product: Avicidin cancer therapy, which uses NERX's pretargeting technology to localize antibodies at tumor sites prior to administration of a radioactive isotope, which binds to th...